48 Results

People

  1. Lin
    Lin
  2. Perales
    Perales
  3. Scordo
    Scordo
  4. Dahi
    Dahi
  5. Shah
    Shah
  6. Palomba
    Palomba
  7. Giralt
    Giralt
  8. Devlin
    Devlin
  9. Salles
    Salles
  10. Alarcon Tomas
    Alarcon Tomas

Groups

  1. Center for Hematologic Malignancies (48)
  2. Department of Medicine (48)
  3. Hematologic Malignancies, Division of (48)
  4. Lymphoma (48)
  5. Survivorship Research (48)
  6. Bone Marrow Transplant (47)
  7. CTCR Scholars (45)
  8. MSK Grad Students (45)
  9. Master of Science in Clinical and Translational Cancer Research (45)
  10. Epidemiology and Biostatistics (33)
  1. "Center for Hematologic Malignancies"
  2. "Lymphoma"
  3. "Richard Lin"
Formats
  1. Meeting Abstract (33)
  2. Journal Article (11)
  3. Research Letter (4)
Groups
  1. Center for Hematologic Malignancies (48)
  2. Department of Medicine (48)
  3. Hematologic Malignancies, Division of (48)
  4. Lymphoma (48)
  5. Survivorship Research (48)
  6. Bone Marrow Transplant (47)

More Groups

People
  1. Richard Lin (48)
  2. Miguel-Angel Perales (47)
  3. Michael Scordo (45)
  4. Gunjan Shah (44)
  5. Parastoo Dahi (44)
  6. Maria Palomba (42)

More People

Years
  1. 2024 (1)
  2. 2023 (23)
  3. 2022 (10)
  4. 2021 (6)
  5. 2020 (4)
  6. 2019 (3)

More Years

Publications
  1. Blood (25)
  2. Transplantation and Cellular Therapy (5)
  3. Hematological Oncology (3)
  4. Blood Advances (2)
  5. Bone Marrow Transplantation (2)
  6. Haematologica (2)

More Publications

Publishers
  1. American Society of Hematology (27)
  2. Elsevier Inc. (6)
  3. Nature Publishing Group (4)
  4. Wiley Blackwell (3)
  5. Ferrata Storti Foundation (2)
  6. American Society of Clinical Oncology (1)

More Publishers

Results (48)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Conventional and novel [(18)F]FDG PET/CT features as predictors of CAR-T cell therapy outcome in large B-cell lymphoma
    Journal Article

    Leithner, D.; Flynn, J. R.; Devlin, S. M.; Mauguen, A.; Fei, T.; Zeng, S.; Zheng, J.; Imber, B. S.; Hubbeling, H.; Mayerhoefer, M. E.; more...
    Journal of Hematology & Oncology (2024)

    Fulltext@MSK | Save
  • Patterns and safety of glucocorticosteroids use following CD19 CAR-T cell therapy for B-cell lymphoma
    Meeting Abstract

    Luttwak, E.; Flynn, J. R.; Devlin, S. M.; Cassanello, G.; Corona, M.; Dahi, P. B.; Luna De Abia, A.; Fein, J.; Giralt, S. A.; Landego, I.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Comparison of bendamustine versus fludarabine/cyclophosphamide lymphodepletion in adult patients receiving CD19 CAR-T cell therapy
    Meeting Abstract

    Landego, I.; Nemirovsky, D.; Devlin, S. M.; Wills, B.; Parascondola, A.; Saldia, A.; Dahi, P. B.; Tomas, A. A.; Ip, A.; Suh, H. C.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • First fever between lymphodepletion and day 30 after CAR-T cell therapy: Patterns, origins, and implications in lymphoma patients
    Meeting Abstract

    Melica, G.; Luna, A.; Fei, T.; Corona, M.; Dahi, P. B.; Fein, J.; Giralt, S. A.; Raj, S.; Landego, I.; Lin, R. J.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • The impact of cardiovascular vulnerabilities in non Hodgkin lymphoma patients treated with chimeric antigen receptor T cell therapy
    Meeting Abstract

    Landego, I.; Flynn, J. R.; Goldman, A.; Devlin, S. M.; Luttwak, E.; Luna De Abia, A.; Corona, M.; Kedmi, M.; Sdayoor, I.; Fried, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Detection of CAR-T cell persistence with digital droplet PCR: Correlation of in vivo expansion with clinical outcomes in a cohort of B-cell lymphoma patients
    Meeting Abstract

    Cassanello, G.; Borsu, L.; Arcila, M. E.; Yao, J.; Boroujeni, A. M.; Ewalt, M.; Patel, U.; Chan, R.; Gray, B.; Luna De Abia, A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • From widespread to tailored antifungal prophylaxis in lymphoma patients treated with CD19 CAR T- cell therapy: Less is better
    Meeting Abstract

    Melica, G.; Luna De Abia, A.; Corona, M.; Fein, J.; Dahi, P. B.; Giralt, S. A.; Landego, I.; Lin, R. J.; Palomba, M. L.; Parascondola, A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Impact of response to systemic bridging therapy on clinical outcomes and cytokine profiles in patients receiving CD19-CAR T-cell therapy for B-cell lymphoma
    Meeting Abstract

    Wills, B.; Shouval, R.; Flynn, J. R.; Devlin, S. M.; Parascondola, A.; Saldia, A.; Imber, B. S.; Tomas, A. A.; Landego, I.; Lin, R. J.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Responses and outcomes after second-line therapy in transplant-eligible patients with DLBCL relapse over 1 year after first-line therapy
    Meeting Abstract

    Qualls, D. A.; Shah, G. L.; Shouval, R.; Caron, P.; David, K. A.; Falchi, L.; Ghione, P.; Hamlin, P. A.; Horwitz, S. M.; Intlekofer, A. M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Evaluation of the impact of tocilizumab use in recipients of CAR T cells for non-Hodgkin lymphoma
    Meeting Abstract

    Cassanello, G.; Luttwak, E.; Devlin, S. M.; Luna De Abia, A.; Corona, M.; Landego, I.; Parascondola, A.; Saldia, A.; Tomas, A. A.; Dahi, P. B.; more...
    Blood (2023)

    Fulltext@MSK | Save